IL-15 and IL-16 overexpression in cutaneous T-cell lymphomas: stage-dependent increase in mycosis fungoides progression.
Cytokines are of major importance for the pathogenesis of cutaneous T-cell lymphomas (CTCL). Recent data suggested that IL-15 and IL-16 are survival/growth factors for the malignant T cells in these entities. To investigate the expression of IL-15 and IL-16 in mycosis fungoides (MF) and CD30+ pleomorphic T-cell lymphoma in vivo, we established a competitive RT-PCR technique. Analyzing skin biopsies from CTCL patients at different stages in comparison to psoriatic and healthy skin, we found IL-15 and IL-16 mRNA overexpression in both CTCL entities. Remarkably, there was some evidence for a stage-dependent increase during MF progression. We found only slight overexpression in early stage MF, when only few tumor cells are detectable within the infiltrates, whereas marked overexpression was found in more advanced lesions, which are characterized by a higher density of malignant cells. These results suggested that CTCL cells themselves might produce the cytokines. To further elucidate this hypothesis, two CTCL cell lines were analyzed but gave conflicting results. Therefore, the cellular origin of the IL-15 and IL-16 overexpression in CTCL remains unclear. Considering the significant overexpression of IL-15 and IL-16 and their biological capacities it is likely that these cytokines contribute to the tumor development. So, they might be involved in growth and skin homing of CTCL cells.
Asadullah
K
K
Department of Dermatology, University Hospital, Charité, Berlin Humboldt University, Germany.
Haeussler-Quade
A
A
Gellrich
S
S
Hanneken
S
S
Hansen-Hagge
T E
TE
Döcke
W D
WD
Volk
H D
HD
Sterry
W
W
D000328:Adult; D001483:Base Sequence; D016022:Case-Control Studies; D017931:DNA Primers / Q000235:genetics; D015870:Gene Expression; D006801:Humans; D019409:Interleukin-15 / Q000235:genetics / Q000378:metabolism*; D019410:Interleukin-16 / Q000235:genetics / Q000378:metabolism*; D017730:Ki-1 Antigen / Q000378:metabolism; D016410:Lymphoma, T-Cell, Cutaneous / Q000209:etiology / Q000276:immunology* / Q000473:pathology; D009182:Mycosis Fungoides / Q000276:immunology; D011565:Psoriasis / Q000276:immunology; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D012334:RNA, Neoplasm / Q000235:genetics / Q000378:metabolism; D012878:Skin Neoplasms / Q000209:etiology / Q000276:immunology* / Q000473:pathology
D017931:DNA Primers; D019409:Interleukin-15; D019410:Interleukin-16; D017730:Ki-1 Antigen; D012333:RNA, Messenger; D012334:RNA, Neoplasm